Surveillance for HIV/AIDS in the United States

Infectious Disease Surveillance: First Edition

Volumn , Issue , 2008, Pages 201-212

  Mokotoff, Eve D ^a   Glynn, M Kathleen ^b  

^a MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiretroviral treatment; Disease control; HIV; Immunology; Opportunistic illness

Indexed keywords

EID: 84891511938     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470692097.ch16     Document Type: Chapter

References (29)

1. Gallo RC, Sallahudin S, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500-3.
2. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lympho-tropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71.
3. Centers for Disease Control and Prevention. Update: Public Health Service Workshop on Human T-Lymphotropic Virus Type III Antibody Testing-United States. MMWR Morb Mortal Wkly Rep 1985;34:477-8.
4. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, 2004. HIV/AIDS Surveill Rep 2005;16:1-46.
5. Fraser DW, Tsai TR, Orenstein W, et al. Legionnaires' disease: description of an epidemic of pneumonia. NEngl J Med 1977;297:1189-97.
6. Fairchild AL, Bayer R, Colgrove J, Wolfe D. Searching Eyes: Privacy, the State, and disease surveillance in America (Berkeley: University of California Press, 2007).
7. Burris S. Surveillance, social risk, and symbolism: framing the analysis for research and policy. J Acquire Immune Defic Syndr 2000;25:S120-7.
8. Morin SF. Early Detection of HIV: Assessing the legislative context. J Acquir Immune Defic Syndr 2000;25:S144-50.
9. Glynn MK, Lee LM, McKenna MT. The status of national HIV case surveillance, United States 2006. Public Health Rep 2007;122(suppl 1):63-71.
10. Ryan White HIV/AIDS Treatment Modernization Act: 2006 Health Resources Services Administration; 2006. Available from: http://hab.hrsa.gov/treatmentmodernization/. Accessed April 25, 2007.
11. Council of State and Territorial Epidemiologists. CSTE Position Statement 05-ID-04: revision of surveillance case definition for AIDS among adults and adolescents ≥13 years of age. Council of State and Territorial Epidemiologists; 2005. Available from: http://www.cste.org/PS/2005pdf/final2005/05-ID-04final.pdf. Accessed July 25, 2006.
12. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recommend Rep 1992;41:1-19.
13. Centers for Disease Control and Prevention. CDC guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recommend Rep 1999;48:1-27.
14. Lindegren ML, Steinberg S, Byers RH, Jr. Epidemiology of HIV/AIDS in children. Pediatr Clin North Am 2000;47:1-20.
15. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recommend Rep 1994;43:1-10.
16. Council of State and Territorial Epidemiologists. CSTE Position Statement 06-ID-02: revision of the surveillance case definition for HIV infection and AIDS among children age >18 months but <13 years. Council of State and Territorial Epidemiologists; 2006. Available from: http://www.cste.org/PS/2006pdfs/PSFINAL2006/06-ID-02FINAL.pdf. Accessed August 5, 2006.
17. McDavid K, McKenna MT. HIV/AIDS risk factor ascertainment: a critical challenge. AIDS Patient Care and STDs 2006;20:285-92.
18. + Tlymphocytes on U.S. AIDS surveillance. J Acquire Immune Defic Syndr 1997;14:56-60.
19. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447-50.
20. Council of State and Territorial Epidemiologists. Position Statement 04-ID-07: Laboratory Reporting of Clinical Test Results Indicative of HIV Infection: New Standards for a New Era of Surveillance and Prevention. Council of State and Territorial Epidemiologists; 2004. Available from: http://www.cste.org/ps/2004pdf/04-ID-07-final.pdf. Accessed April 25, 2007.
21. Centers for Disease Control and Prevention. Technical Guidance for HIV/AIDS Surveillance Programs, Volume III: Security and Confidentiality Guidelines. Centers for Disease Control and Prevention; 2006. Available from: http://www.cdc.gov/hiv/topics/surveillance/resources/guidelines/guidance/index.htm. Accessed October 1, 2006.
22. Council of State and Territorial Epidemiologists. Position Statement 02-ID-04: surveillance for perinatal HIV exposure. Council of State and Territorial Epidemiologists; 2004. Available from: http://www.cste.org/position% 20statements/02-ID-04.pdf. Accessed October 1, 2006.
23. Green TA. Using surveillance data to monitor trends in the AIDS epidemic. Stat Med 1998;17:143-54.
24. Michigan Department of Community Health. Annual Review of HIV Trends in Michigan 2001-2005. Michigan Department of Community Health; 2007. Available from: http://www.michigan.gov/documents/mdch/MIReport07 195579 7.pdf. Accessed May 7, 2007.
25. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Lyss SB, Clark JE. Revised Recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recommend Rep 2006;55:1-17.
26. + T-cell counts at HIV diagnosis in Southeast Michigan, 1992-2002. Medscape Gen Med 2005. Available from: http://www.medscape.com/viewarticle/498351. Accessed March 16, 2005.
27. Centers for Disease Control and Prevention and Health Resources Services Administration. Integrated Guidelines for Developing Epidemiologic Profiles: HIV Prevention and Ryan White CARE Act Community Planning. Centers for Disease Control and Prevention; 2004. Available from: http://www.cdc.gov/hiv/epi guidelines.htm. Accessed October 1, 2006.
28. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-8.
29. Lee LM, McKenna MT. Monitoring the incidence of HIV infection in the United States. Public Health Rep 2007;122(suppl 1):72-9.